24 September 2023 Global Initiative for Asthma (GINA) submission to ECHA REACH on proposal to restrict PFAS GINA response to consultaon on proposed restricon on the manufacture, placing on the market and use of per- and polyfluoroalkyl substances (PFAS) Use sector: Medical devices.

Environmental Toxicology and Chemistry--Volume 00, Number 00--pp. 1-11, 2020 Received: 30 March 2020 I Revised: 18 May 2020 I Accepted: 12 June 2020 1 Per- and Polyfluoroalkyl Substances Environmental Assessment of Various End-of-Life Pathways for Treating Per- and Polyfluoroalkyl Substances in Spent Fire-Extinguishing Waters Daniel Maga, Venkat Aryan,* and Stefano Bruzzano Fraunhofer Institute for Environmental, Safety, and Energy Technology (UMSICHT), Oberhausen, Germany Abstract: Per- and polyfluoroalkyl substances (PFAS) are now thought to be far more prevalent in water bodies across the globe than previously reported.

Login details: See below Draft agenda for PFAS-RESTRICTION 27 WEBEX Meeting between DE, DK, NL, NO, SE CA, ECHA and COM 25 April, 9:00 - 13:00 (CET) Point 1 - Opening and adoption of the agenda (09:00 - 09:10 am) Point 2 - Status of COM/ECHA restriction on firefighting foams (09:10 - 09:25 am) - Status update/next steps COM to leave here.

Apr 25, 2023 Comment on Proposed Restriction of PFAS Conference of Fluoro-Chemical Product Japan (FCJ) On behalf of chemical manufacturers, we, Conference of Fluoro-Chemical Product Japan (FCJ), have been working tirelessly to comply with national chemical regulations.

EUROPEAN MEDICINES AGENCY SCIENCE MEDICINES HEALTH 1 30 March 2023 2 EMA/CHMP/83033/2023 3 Committee for Medicinal Products for Human Use (CHMP) 4 Questions and answers on data requirements when 5 replacing hydrofluorocarbons as propellants in oral 6 pressurised metered dose inhalers 7 8 Agreed by Rheumatology and Immunology Working Party February 2023 Adopted by CHMP for release for consultation 30 Mar 2023 Start of public consultation April 2023 End of consultation (deadline for comments) 9 10 31 May 2023 Comments should be provided using this template.

UNIVERSITY HOSPITAL RHEINISCH-WESTFALISCHE TECHNISCHE HOCHSCHULE AACHEN CLINIC FOR GENERAL, VISCERAL AND TRANSPLANT SURGERY Director: University Professor Dr. med.

EFCTC EFCTC POSITION PAPER August 2021 Published evidence supports very low yield of TFA from most HFOs and HCFOs Summary EFCTC has analysed the most current, peer reviewed scientific papers on the potential contribution of HFOs and HCFOs, containing the CF3CH= moiety, to existing and future TFA levels.

Classification: General Business Use SHPP's Inputs to the Public Consultation Comments to Annex XV PFAS Restriction Proposal Question number 6: Missing uses: PTFE Used in Internally Lubricated Thermoplastic Compounds Previous ECHA Submission Ref.: Comment Ref. 3981 Executive Summary SABIC's Specialties business (SHPP) produces a range of highly differentiated products, including high-performance thermoplastics, compounds, and additives that meet complex thermal, mechanical, optical, and electrical property requirements.

July 31, 2020 Comments for call for evidence on PFASs Dear Sirs and Madams: On behalf of Japan Cosmetic Industry Association (JCIA) representing interest of more than one thousand Japanese cosmetic companies, I would like to express my sincere gratitude to your great efforts to tackle the emerging issues such as PFASs to protect and preserve the global environment.

W.

PM 2022 Dnr nr 2021/04303 Vetenskapligt underlag fr PFAS i dricksvatten _______________ Denna titel kan laddas ner frn: Livsmedelsverkets publikationer Citera grna Livsmedelsverkets texter, men glm inte att uppge kllan.

HONEYWELL ADVANCED LIMITED RIVERVIEW HOUSE HARVEY'S QUAY APARTMENTS LIMERICK V94R3DE IRELAND 27June 2023 PFAS REACH Annex XV Restriction Report 1ST Public Consultation (22 March - 25 September 2023) Request for Exclusion or Derogation of pMDIs Propellants from PFAS REACH Restriction Proposal Executive summary Honeywell International Inc.

Comment on Proposed Restriction of PFAS Jul 31, 2023 Japan Valve Manufacturers' Association (JVMA) Japan Valve Manufacturers Association (JVMA) appreciates the opportunity to provide comments to the PFAS restriction proposal. 1.

ELSEVIER Regulatory Toxicology and Pharmacology 134 (2022) 105226 Contents lists available at ScienceDirect Regulatory Toxicology and Pharmacology journal homepage: www.elsevier.com/locate/yrtph Grouping of PFAS for human health risk assessment: Findings from an independent panel of experts J.K.

Application for exemption from EU REACH PFAS control for fluoropolymers (PTFE) Topic: Application for Permanent Exemption for Fluoropolymers (PTFE) Reasons: The first polymer itself poses little threat to the environment and the human body; The second is that the processing AIDS used in the production of polymers have been controlled or promoted to use alternative substances;The third is that PTFE is the fluoropolymer of choice for many medical device coating applications, and the human body has no rejection phenomenon.